Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease.
about
Hepatitis C virus core variants isolated from liver tumor but not from adjacent non-tumor tissue interact with Smad3 and inhibit the TGF-beta pathwayRegulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-IGeneration of immune responses against hepatitis C virus by dendritic cells containing NS5 protein-coated microparticlesAnalysis of CD127 and KLRG1 expression on hepatitis C virus-specific CD8+ T cells reveals the existence of different memory T-cell subsets in the peripheral blood and liverEvidence for a functional RNA element in the hepatitis C virus core geneCellular immune response to hepatitis-C-virus in subjects without viremia or seroconversion: is it important?The influence of the workplace-related biological agents on the immune systems of emergency medical personnelNK cell function and receptor diversity in the context of HCV infectionImmune and non-immune responses to hepatitis C virus infectionImmune responses to HCV and other hepatitis virusesT cell responses in hepatitis C virus infection: historical overview and goals for future researchViral quasispecies evolutionT cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection.An Interplay between Hypervariable Region 1 of the Hepatitis C Virus E2 Glycoprotein, the Scavenger Receptor BI, and High-Density Lipoprotein Promotes both Enhancement of Infection and Protection against Neutralizing AntibodiesRobust hepatitis C virus infection in vitro.Stealth and cunning: hepatitis B and hepatitis C viruses.Parenchymal expression of CD86/B7.2 contributes to hepatitis C virus-related liver injury.Liver-directed gamma interferon gene delivery in chronic hepatitis C.Nonlinear partial differential equations and applications: Genomic analysis of the host response to hepatitis C virus infectionEvolution of hepatitis C viral quasispecies and hepatic injury in perinatally infected children followed prospectivelyKinetics of CD4+ and CD8+ Memory T-Cell Responses during Hepatitis C Virus Rechallenge of Previously Recovered ChimpanzeesCell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitroVirus-induced type I IFN stimulates generation of immunoproteasomes at the site of infectionFrequent Recovery and Broad Genotype 2 Diversity Characterize Hepatitis C Virus Infection in Ghana, West AfricaImpaired Hepatitis C Virus-Specific T Cell Responses and Recurrent Hepatitis C Virus in HIV CoinfectionMultispecific T cell response and negative HCV RNA tests during acute HCV infection are early prognostic factors of spontaneous clearanceClearance of low levels of HCV viremia in the absence of a strong adaptive immune responseIn Vivo Study of the HC-TN Strain of Hepatitis C Virus Recovered from a Patient with Fulminant Hepatitis: RNA Transcripts of a Molecular Clone (pHC-TN) Are Infectious in Chimpanzees but Not in Huh7.5 CellsHepatitis C Virus Envelope Glycoprotein E2 Glycans Modulate Entry, CD81 Binding, and NeutralizationHepatitis C Virus Infection Induces the Beta Interferon Signaling Pathway in Immortalized Human HepatocytesHepatitis C virus RNA: Dinucleotide frequencies and cleavage by RNase LMemory CD8+ T cells are required for protection from persistent hepatitis C virus infectionIncreased Cytotoxic T-Lymphocyte Epitope Variant Cross-Recognition and Functional Avidity Are Associated with Hepatitis C Virus ClearanceVirus-Specific T-Cell Immunity Correlates with Control of GB Virus B Infection in MarmosetsScavenger Receptor Class B Is Required for Hepatitis C Virus Uptake and Cross-Presentation by Human Dendritic CellsInterferon signaling and treatment outcome in chronic hepatitis CLack of response to exogenous interferon-α in the liver of chimpanzees chronically infected with hepatitis C virusHepatitis C Virus (HCV)-Induced Immunoglobulin Hypermutation Reduces the Affinity and Neutralizing Activities of Antibodies against HCV Envelope ProteinCorrelation between pre-treatment quasispecies complexity and treatment outcome in chronic HCV genotype 3aStable Cytotoxic T Cell Escape Mutation in Hepatitis C Virus Is Linked to Maintenance of Viral Fitness
P2860
Q24307549-35641365-0D13-4D71-AA91-67BD30076465Q24556673-764C2102-E4AB-45AB-AF53-B1F308B1A40AQ24652467-75C1BA64-42AD-4A47-9787-475DB355F4ECQ24675828-A0BAF3EA-BD13-4579-833A-6C536AF62ED6Q24682695-37B9122E-2E33-4581-AD28-66E69DF3A09AQ26749249-BE5656ED-A22A-4078-8FE4-D9154E1700A7Q26777979-5F53EBF4-208D-4133-9EF1-797D7FCCABB2Q26781537-9DD6D761-5785-475D-867A-383E44D8CE9BQ26782040-1FEFB7A0-6C84-49B8-BA69-F4C5D412A729Q26866955-CD916078-5226-4E8D-B319-85CE9A21A548Q27003510-B515C47F-3502-4BA9-BC41-B7450EF29817Q27013917-E84C1D9C-29A8-40A4-91B9-5924F9E0C398Q27469830-EAE05129-ECC4-48C5-8018-10496E151623Q27469837-ADC9CF43-AE70-46E5-B5DF-34A656A6431AQ27470013-989DF725-95EF-4E2D-8B01-482DC40F8DF6Q27470232-96F022C8-AB1B-419B-9F0F-F2BA734AFEDDQ27470502-3B094DA8-F3F6-4F00-9184-53B454934087Q27472673-573CCBD4-5C73-4C48-84FE-35991B489E4AQ27473003-70EF9E0B-8B1A-481E-872B-6498BAB296B3Q27473267-C1F94606-4760-419E-A164-C3B5F271AE35Q27473402-BC21B4C6-F752-4EE3-90A7-09701148BA82Q27473436-D8F3B28C-CA10-44E8-BF9F-8AE7B1C380FCQ27477499-BCCA3CAF-A96D-4F74-8964-B2E68AB9B6E5Q27477557-60EC8A95-15E5-4E3E-8F3E-551A13DECBA7Q27477797-7030B873-C6E3-444F-B5E3-912BA621515AQ27477974-A2BC5991-3856-4E3B-83DE-C81BC65B4250Q27480809-4EF10F63-6BA2-4C0E-8AA3-CCC9553A452AQ27480932-5F106C23-DDFE-4423-92EF-A5399B019276Q27481012-FFA5790F-5E21-457D-9A6F-E0F090EAEEEDQ27485023-50438DE9-0AC6-4A40-8EF8-E75C76F247ABQ27485064-AD57B455-FC85-4A94-B549-045F933E745DQ27485119-E179A8E1-80DB-4451-8F38-3D84CFB42216Q27485452-D3F44EF6-9267-4ABF-A412-51BA7848E8D4Q27485455-914C4FC1-CFC3-4A36-9886-02193165E34FQ27485559-C8429592-BABE-4EDE-936E-7362020621DAQ27486083-691030CE-661F-4C66-9C20-579FEA44C646Q27486088-F0722349-7EBC-4E27-93A0-90F8C9D7F79DQ27486411-EB6526E5-68BB-46F2-8B1F-1D22C5EA7023Q27486521-AEB0DE67-E9F0-4F24-93AE-CF82A3AE3184Q27486654-195ED1E5-A499-4ABE-B2CB-C66085C68257
P2860
Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease.
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
Viral and immunological determ ...... ance, persistence, and disease
@nl
Viral and immunological determ ...... nce, persistence, and disease.
@ast
Viral and immunological determ ...... nce, persistence, and disease.
@en
type
label
Viral and immunological determ ...... ance, persistence, and disease
@nl
Viral and immunological determ ...... nce, persistence, and disease.
@ast
Viral and immunological determ ...... nce, persistence, and disease.
@en
prefLabel
Viral and immunological determ ...... ance, persistence, and disease
@nl
Viral and immunological determ ...... nce, persistence, and disease.
@ast
Viral and immunological determ ...... nce, persistence, and disease.
@en
P2093
P2860
P3181
P356
P1476
Viral and immunological determ ...... nce, persistence, and disease.
@en
P2093
Carola Steiger
Hans Christian Spangenberg
Janell Pemberton
Robert H Purcell
Robert Thimme
Stefan Wieland
Sugantha Govindarajan
P2860
P304
15661-15668
P3181
P356
10.1073/PNAS.202608299
P407
P577
2002-11-19T00:00:00Z